Generated: December 13, 2017
DrugPatentWatch Database Preview
Details for Patent: 6,984,403
« Back to Dashboard
Which drugs does patent 6,984,403 protect, and when does it expire?
Summary for Patent: 6,984,403
|Title:||Azithromycin dosage forms with reduced side effects|
|Abstract:||The present invention is related to an oral dosage form comprising an effective amount of an alkalizing agent and an azithromycin multiparticulate wherein said multiparticulate comprises azithromycin, a glyceride which comprises glyceryl monobehenate, glyceryl dibehenate, glyceryl tribehenate, or a mixture thereof and a poloxamer. Typically, the oral dosage form includes any suitable oral dosing means such as a powder for oral suspension, a unit dose packet or sachet, a tablet or a capsule.|
|Inventor(s):|| Hagen; Timothy A. (East Lyme, CT), Lo; Julian B. (Old Lyme, CT), Thombre; Avinash G. (East Lyme, CT), Herbig; Scott M. (East Lyme, CT), Appel; Leah Elizabeth (Bend, OR), Crew; Marshall David (Bend, OR), Friesen; Dwayne Thomas (Bend, OR), Lyon; David Keith (Bend, OR), McCray; Scott Baldwin (Bend, OR), West; James Blair (Bend, OR) |
|Assignee:|| Pfizer Inc. (New York, NY) |
Patent Claim Types:|
see list of patent claims
|Dosage form; Use; Composition; |
||Patented / Exclusive Use
|Pf Prism Cv||ZMAX||azithromycin||FOR SUSPENSION, EXTENDED RELEASE;ORAL||050797-001||Jun 10, 2005||RX||Yes||Yes||► Subscribe||► Subscribe||► Subscribe||Y||METHOD OF TREATING BACTERIAL INFECTIONS|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
International Patent Family for Patent: 6,984,403
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.